Table 1 Age at diagnosis, tumor characteristics and treatment given in the TNP and non-TNP groups.
From: Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Clinical Feature | No. of cases Non-TNP | No. of cases TNP | Odds Ratio [95% CI] | P-value* | |
|---|---|---|---|---|---|
Center | VGH | 228 | 36 | ||
JGH | 165 | 27 | 1.04 [0.61; 1.77] | 0.89 | |
Age at diagnosis | 25–49 years | 116 | 32 | ||
50–95 years | 277 | 31 | 0.41 [0.24; 0.70] | 0.001 | |
Histological grade | Grade 1 | 120 | 4 | ||
Grade 2 | 193 | 15 | 2.33 [0.76; 7.19] | 0.15 | |
Grade 3 | 68 | 40 | 17.65 [6.05; 51.45] | <0.0001 | |
Missing | 12 | 4 | |||
Tumor size | 0–2 cm | 161 | 18 | ||
2.01–15 cm | 217 | 45 | 1.85 [1.04; 3.32] | 0.04 | |
Missing | 15 | 0 | |||
Lymph node status | Negative | 205 | 41 | ||
Positive | 149 | 13 | 0.44 [0.23; 0.84] | 0.01 | |
Missing | 39 | 9 | |||
Hormonal Treatment | None | 219 | 49 | ||
Yes | 161 | 11 | 0.31 [0.15; 0.61] | 0.0003 | |
Missing | 13 | 3 | |||
Chemotherapy | None | 279 | 35 | ||
Yes | 108 | 26 | 1.92 [1.10; 3.34) | 0.02 | |
Missing | 6 | 2 | |||